We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+19.66%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$870M
AUM Growth
-$294M
(-25%)
Cap. Flow
-$431M
Cap. Flow
% of AUM
-49.59%
Top 10 Holdings %
Top 10 Hldgs %
24.31%
Holding
125
New
9
Increased
9
Reduced
74
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$7.93M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$6.31M |
| 3 |
ICU Medical
ICUI
|
+$5.89M |
| 4 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
+$5.51M |
| 5 |
EVRI
Everi Holdings
EVRI
|
+$5.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$18.2M |
| 2 |
QUOT
Quotient Technology Inc
QUOT
|
+$14.9M |
| 3 |
INXN
Interxion Holding N.V.
INXN
|
+$14.3M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$12.2M |
| 5 |
Medifast
MED
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32% |
| 2 | Technology | 14.68% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Industrials | 10.97% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zurn Elkay Water Solutions
ZWS
$8.38B
| $10.9M | 1.25% |
693,602
-151,473
| -18% | -$2.18M |
|
27
Heron Therapeutics
HRTX
$93.9M
| $10.9M | 1.25% |
462,574
-163,062
| -26% | -$3.61M |
|
28
Healthcare Services Group
HCSG
$1.6B
| $10.8M | 1.25% |
446,095
-216,540
| -33% | -$5.36M |
|
|
MTOR
29
DELISTED
MERITOR, Inc.
MTOR
| $10.7M | 1.23% |
407,918
-223,062
| -35% | -$5.03M |
|
|
STMP
30
DELISTED
Stamps.com, Inc.
STMP
| $10.6M | 1.22% |
126,879
-53,788
| -30% | -$4.48M |
|
|
CVSA
31
Covista Inc
CVSA
$4.25B
| $10.4M | 1.19% |
296,313
-117,939
| -28% | -$4.06M |
|
32
Essent Group
ESNT
$6.08B
| $10.3M | 1.19% |
199,044
-102,652
| -34% | -$5.35M |
|
33
Artivion
AORT
$1.3B
| $10.1M | 1.16% |
372,948
+56,016
| +18% | +$1.38M |
|
|
NGHC
34
DELISTED
National General Holdings Corp
NGHC
| $10.1M | 1.16% |
456,178
-174,911
| -28% | -$3.82M |
|
|
WMGI
35
DELISTED
Wright Medical Group Inc
WMGI
| $9.95M | 1.14% |
326,328
-343,479
| -51% | -$8.99M |
|
36
Pathward Financial
CASH
$1.86B
| $9.74M | 1.12% |
266,760
+4,116
| +2% | +$140K |
|
37
National Vision
EYE
$1.77B
| $9.51M | 1.09% |
293,078
-131,517
| -31% | -$3.62M |
|
|
VRAY
38
DELISTED
ViewRay, Inc.
VRAY
| $8.9M | 1.02% |
2,108,124
+785,785
| +59% | +$2.54M |
|
39
EnerSys
ENS
$6.78B
| $8.85M | 1.02% |
118,221
-63,731
| -35% | -$4.41M |
|
40
Karyopharm Therapeutics
KPTI
$43.5M
| $8.82M | 1.01% |
30,687
-54,028
| -64% | -$11.7M |
|
41
Acadia Healthcare
ACHC
$2.76B
| $8.74M | 1.01% |
263,225
-120,629
| -31% | -$3.78M |
|
|
TCF
42
DELISTED
TCF Financial Corporation Common Stock
TCF
| $8.71M | 1% |
186,151
-87,364
| -32% | -$3.62M |
|
|
AMRN
43
Amarin Corp
AMRN
$299M
| $8.39M | 0.96% |
19,568
-20,373
| -51% | -$7.74M |
|
|
FOLD
44
DELISTED
Amicus Therapeutics
FOLD
| $8.37M | 0.96% |
859,306
-131,499
| -13% | -$1.2M |
|
|
NXGN
45
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $8.12M | 0.93% |
505,323
-276,324
| -35% | -$4.57M |
|
46
Yeti Holdings
YETI
$3.71B
| $8M | 0.92% |
229,984
-12,259
| -5% | -$386K |
|
47
Boot Barn
BOOT
$4.51B
| $7.99M | 0.92% |
179,440
-42,552
| -19% | -$1.68M |
|
|
48
Agios Pharmaceuticals
AGIO
$1.79B
| $7.97M | 0.92% |
+166,922
| New | +$6.31M |
|
49
Enerpac Tool Group
EPAC
$1.83B
| $7.95M | 0.91% |
305,317
-163,747
| -35% | -$4M |
|
50
Caesars Entertainment
CZR
$6.06B
| $7.92M | 0.91% |
132,729
-72,582
| -35% | -$3.59M |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Elk Creek Partners held 125 positions worth $870M, down 25% from $1.16B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Elk Creek Partners withdrew a net $431M in Q4 2019, closing 33 positions and reducing 74 holdings. Its most notable exit was Exact Sciences, an estimated $12.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Elk Creek Partners opened a new position in Terminix Global Holdings, Inc. worth $7.21M.
- Elk Creek Partners's largest Q4 2019 buy was Terminix Global Holdings, Inc.: 186,365 shares worth $7.21M.
- Elk Creek Partners added most to ViewRay, Inc. in Q4 2019, an estimated $2.54M increase.
- Elk Creek Partners's biggest Q4 2019 reduction was Clovis Oncology, Inc., cutting an estimated $18.2M.
- Elk Creek Partners fully exited Exact Sciences in Q4 2019, selling an estimated $12.2M.
- Elk Creek Partners's ten largest holdings make up 24% of its $870M portfolio in Q4 2019.
- Elk Creek Partners opened 9 new positions and closed 33 in Q4 2019.
- Elk Creek Partners's portfolio value fell 25% quarter-over-quarter to $870M.
Based on Elk Creek Partners's 13F filing for Q4 2019, filed 14 Feb 2020.